FREE EXPRESS SHIPPING ON ORDERS OVER $200
Tirzepatide
$189.00
Tirzepatide (5mg) is a groundbreaking dual GIP/GLP-1 receptor agonist designed for effective weight management and metabolic improvement. This innovative peptide works by targeting two crucial hormone pathways simultaneously—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)—to regulate appetite, enhance satiety, and optimise glucose metabolism. Unlike traditional weight loss approaches, Tirzepatide's dual-action mechanism provides exceptional results while supporting vital metabolic functions. Clinical studies have shown impressive weight reduction outcomes, with subjects experiencing significant fat loss while maintaining muscle mass, establishing Tirzepatide as a powerful option for those seeking meaningful and sustainable weight management results.
Elevate your weight management strategy with Fragment's Tirzepatide—a powerful dual-action peptide scientifically formulated to deliver substantial weight loss benefits while enhancing metabolic health and supporting your long-term wellness goals.
Note: These peptides are not tablets—they are shipped as lyophilized powder with water provided separately. Peptides are injected subcutaneously.
Why Choose Tirzepatide?
- Dual-Action Mechanism: Simultaneously activates GIP and GLP-1 receptors for powerful weight management effects beyond single-target treatments.
- Enhanced Satiety Control: Effectively suppresses appetite and prolongs feelings of fullness, making dietary adherence easier and more sustainable.
- Superior Glycemic Management: Significantly improves insulin sensitivity and glucose control, making it particularly beneficial for those with insulin resistance or type 2 diabetes.
- Impressive Weight Loss Results: Clinical studies show remarkable efficacy with participants achieving 10-20% total body weight reduction, surpassing many other weight management options.
- Metabolic Health Improvements: Provides substantial benefits to overall metabolic health, including favorable changes in cholesterol profiles, blood pressure, and liver function markers.
Who Benefits from Tirzepatide?
Tirzepatide is perfect for individuals pursuing effective weight management alongside improved metabolic health, particularly for those who haven't found success with traditional approaches. It's especially valuable for people with type 2 diabetes or insulin resistance who need both weight control and blood sugar management in one treatment. This dual-action peptide serves as an excellent choice for individuals with moderate to high BMIs seeking clinically significant weight reduction without extreme measures. Tirzepatide provides an optimal solution for those looking for a scientifically-proven intervention that addresses both appetite regulation and metabolic function. With its impressive efficacy and dual benefits, it's particularly well-suited for individuals seeking a comprehensive approach to weight loss that also delivers meaningful improvements in overall health markers and quality of life.
Dosage and Usage
- Recommended Dosage: Start with 2.5 mg/week via subcutaneous injection for the first 4 weeks, then gradually increase by 2.5 mg every 4 weeks: 5 mg/week for weeks 5-8, 7.5 mg/week for weeks 9-12, up to a maximum of 15 mg/week as tolerated.
- Cycle Duration: 12-16 weeks for optimal weight reduction and metabolic improvements, with evaluation periods recommended throughout.
- Administration Schedule: Weekly injections at consistent intervals, preferably on the same day each week to maintain stable blood levels.
BEST SELLERS
HOW TO USE
1
Inside your package, you'll see the peptides and water provided in separate vials. Keep the peptides stored in the freezer until you're ready to reconstitute them.
2
For reconstitution, mix your peptides with at least 1 ml but no more than 3 ml of the supplied water (WFI).
3
Once reconstituted, it's highly recommended to store all compounds in the refrigerator both before and after each use.
4
If you have any questions regarding dosage protocols, please refer to the information below for guidance.
